Daeun Chung

New Developments in Anthracycline-Induced Cardiotoxicity

Doxorubicin pathways

Prodrug Strategies in Anticancer Chemotherapy

Synthesis, cytotoxicity, and structure–activity relationship (SAR) studies of andrographolide analogues as anti-cancer agent

Encoded libraries of chemically modified peptides

Environmentally responsive peptides as anticancer drug carriers☆

The 6‐maleimidocaproyl hydrazone derivative of doxorubicin (DOXO‐EMCH) is superior to free doxorubicin with respect to cardiotoxicity and mitochondrial damage

DOXO-EMCH (INNO-206): the first albumin-binding prodrug of doxorubicin to enter clinical trials

Protease-Activated Drug Development

A Bioorthogonal Reaction of N‐Oxide and Boron Reagents

Andrographolide and its analogues: versatile bioactive molecules for combating inflammation and cancer

Albumin as a drug carrier: Design of prodrugs, drug conjugates and nanoparticles

Engineered Nanoparticles for Drug Delivery in Cancer Therapy

Endocytosis at the nanoscale

Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)

Development of Albumin-Binding Camptothecin Prodrugs Using a Peptide Positional Scanning Library

Click chemistry connections for functional discovery

Synthesis, Cleavage Profile, and Antitumor Efficacy of an Albumin‐Binding Prodrug of Methotrexate that is Cleaved by Plasmin and Cathepsin B

Surface-Enhanced Raman Spectroscopy for Bioanalysis: Reliability and Challenges

Degradable Conjugates from Oxanorbornadiene Reagents

Nanoparticles in Photodynamic Therapy

A Doxorubicin Prodrug Activated by the Staudinger Reaction

Nanoparticle PEGylation for Imaging and Therapy

Phase I and Pharmacokinetic Study of the (6-Maleimidocaproyl)Hydrazone Derivative of Doxorubicin

Stabilized Integrin-Targeting Ternary LPD (Lipopolyplex) Vectors for Gene Delivery Designed To Disassemble Within the Target Cell

Acute and repeat-dose toxicity studies of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin (DOXO-EMCH), an albumin-binding prodrug of the anticancer agent doxorubicin

Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy

Contribution of Linker Stability to the Activities of Anticancer Immunoconjugates

Calcium phosphates in biomedical applications: materials for the future?

A Bioorthogonal Reaction of N‐Oxide and Boron Reagents

Prodrugs of Anthracyclines in Cancer Chemotherapy

Synthesis and biological evaluation of an albumin‐binding prodrug of doxorubicin that is cleaved by prostate‐specific antigen (PSA) in a PSA‐positive orthotopic prostate carcinoma model (LNCaP)

Development of a novel albumin-binding prodrug that is cleaved by urokinase-type-plasminogen activator (uPA)

Albumin-Binding Prodrugs of Camptothecin and Doxorubicin with an Ala-Leu-Ala-Leu-Linker That Are Cleaved by Cathepsin B:  Synthesis and Antitumor Efficacy